These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1905872)

  • 21. Evaluation of regional cerebral blood flow using single photon emission tomography for the selection of patients for local fibrinolytic therapy of acute cerebral embolism.
    Ezura M; Takahashi A; Yoshimoto T
    Neurosurg Rev; 1996; 19(4):231-6. PubMed ID: 9007885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke.
    Barreto AD; Fanale CV; Alexandrov AV; Gaffney KC; Vahidy FS; Nguyen CB; Sarraj A; Rahbar M; Grotta JC; Savitz SI;
    Ann Neurol; 2016 Aug; 80(2):211-8. PubMed ID: 27273860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.
    Weimar C; Kraywinkel K; Maschke M; Diener HC;
    Cerebrovasc Dis; 2006; 22(5-6):429-31. PubMed ID: 16912477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
    Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
    Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of cerebral vasoreactivity by SPECT and transcranial Doppler sonography using the acetazolamide test.
    Pávics L; Grünwald F; Barzó P; Ambrus E; Menzel C; Schomburg A; Borda L; Máté E; Bodosi M; Csernay L
    Nuklearmedizin; 1994 Dec; 33(6):239-43. PubMed ID: 7854920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of acute embolic stroke outcome after local intraarterial thrombolysis: value of pretreatment and posttreatment 99mTc-ethyl cysteinate dimer single photon emission computed tomography.
    Ogasawara K; Ogawa A; Doi M; Konno H; Suzuki M; Yoshimoto T
    J Cereb Blood Flow Metab; 2000 Nov; 20(11):1579-86. PubMed ID: 11083233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravenous thrombolysis patients with acute ischemic stroke--the analysis of the 100 cases. Part II. Neuroimaging, the analysis of hemorrhagic complications and deaths].
    Sobolewski P; Sledzińska M; Szczuchniak W; Grzesik M; Sobota A; Hatalska-Zerebiec R
    Przegl Lek; 2012; 69(6):242-6. PubMed ID: 23094436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options.
    Umemura A; Suzuka T; Yamada K
    J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):472-8. PubMed ID: 10990507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective and retrospective studies of recovery in aphasia. Changes in cerebral blood flow and language functions.
    Mimura M; Kato M; Kato M; Sano Y; Kojima T; Naeser M; Kashima H
    Brain; 1998 Nov; 121 ( Pt 11)():2083-94. PubMed ID: 9827768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
    Kremer C; Kappelin J; Perren F
    J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
    Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical blood flow and cognition after extracranial-intracranial bypass in a patient with severe carotid occlusive lesions. A three-year follow-up study.
    Tsuda Y; Yamada K; Hayakawa T; Ayada Y; Kawasaki S; Matsuo H
    Acta Neurochir (Wien); 1994; 129(3-4):198-204. PubMed ID: 7847164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke.
    Felberg RA; Okon NJ; El-Mitwalli A; Burgin WS; Grotta JC; Alexandrov AV
    Stroke; 2002 May; 33(5):1301-7. PubMed ID: 11988607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
    von Kummer R; Hacke W
    Stroke; 1992 May; 23(5):646-52. PubMed ID: 1579960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catastrophic Secondary Infarctions with Onset Seizure Following Tissue Plasminogen Activator Therapy.
    Matsuzono K; Nagaoka L; Suzuki M; Kim Y; Ozawa T; Mashiko T; Shimazaki H; Koide R; Fujimoto S
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):e24-e26. PubMed ID: 30655041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes.
    Suarez JI; Zaidat OO; Sunshine JL; Tarr R; Selman WR; Landis DM
    Neurosurgery; 2002 Feb; 50(2):251-9; discussion 259-60. PubMed ID: 11844259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.